Cargando…

A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase

Influenza A virus (IAV) causes seasonal epidemics and occasional but devastating pandemics, which are major public health concerns. Because the effectiveness of seasonal vaccines is highly variable and the currently available drugs are limited in their efficacy because of the emergence of drug resis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ping, Cui, Qinghua, Wang, Lin, Zhao, Xiujuan, Zhang, Yingying, Manicassamy, Balaji, Yang, Yong, Rong, Lijun, Du, Ruikun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024319/ https://www.ncbi.nlm.nih.gov/pubmed/29899269 http://dx.doi.org/10.3390/v10060325

Ejemplares similares

Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase
por: Wang, Lin, et al.
Publicado: (2019)

Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy
por: Zhao, Xiujuan, et al.
Publicado: (2022)

A Recombinant Porcine Reproductive and Respiratory Syndrome Virus Stably Expressing a Gaussia Luciferase for Antiviral Drug Screening Assay and Luciferase-Based Neutralization Assay
por: Li, Yanhua, et al.
Publicado: (2022)

A Mechanism Underlying Attenuation of Recombinant Influenza A Viruses Carrying Reporter Genes
por: Zhao, Xiujuan, et al.
Publicado: (2018)

In Vivo Imaging of Ligand Receptor Binding with Gaussia Luciferase Complementation
por: Luker, Kathryn E., et al.
Publicado: (2011)

Functional multiplex reporter assay using tagged Gaussia luciferase
por: van Rijn, Sjoerd, et al.
Publicado: (2013)

Gaussia Luciferase as a Reporter for Quorum Sensing in Staphylococcus aureus
por: Blower, Isobel, et al.
Publicado: (2020)

A reporter system for assaying influenza virus RNP functionality based on secreted Gaussia luciferase activity
por: Zhu, Wenfei, et al.
Publicado: (2011)

Development of recombinant rabies viruses vectors with Gaussia luciferase reporter based on Chinese vaccine strain CTN181
por: Du, Jialiang, et al.
Publicado: (2011)

Application of Gaussia luciferase in bicistronic and non-conventional secretion reporter constructs
por: Luft, Christin, et al.
Publicado: (2014)

Influenza A Virus Encoding Secreted Gaussia Luciferase as Useful Tool to Analyze Viral Replication and Its Inhibition by Antiviral Compounds and Cellular Proteins
por: Eckert, Nadine, et al.
Publicado: (2014)

A Recombinant Genotype I Japanese Encephalitis Virus Expressing a Gaussia Luciferase Gene for Antiviral Drug Screening Assay and Neutralizing Antibodies Detection
por: Li, Chenxi, et al.
Publicado: (2022)

Imaging Tumor Vascularity and Response to Anti-Angiogenic Therapy Using Gaussia Luciferase
por: Kantar, Rami S., et al.
Publicado: (2016)

Truncated Variants of Gaussia Luciferase with Tyrosine Linker for Site-Specific Bioconjugate Applications
por: Hunt, Eric A., et al.
Publicado: (2016)

Secreted dual reporter assay with Gaussia luciferase and the red fluorescent protein mCherry
por: Wider, Diana, et al.
Publicado: (2017)

A Cytoplasmic Form of Gaussia luciferase Provides a Highly Sensitive Test for Cytotoxicity
por: Tsuji, Saori, et al.
Publicado: (2016)

A general method for quantifying ligand binding to unmodified receptors using Gaussia luciferase
por: Tóth, András Dávid, et al.
Publicado: (2021)

Lignans and Their Derivatives from Plants as Antivirals
por: Cui, Qinghua, et al.
Publicado: (2020)

Secreted Gaussia Luciferase as a Biomarker for Monitoring Tumor Progression and Treatment Response of Systemic Metastases
por: Chung, Euiheon, et al.
Publicado: (2009)

Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
por: Gläsker, Sabine, et al.
Publicado: (2013)

Easy detection of hormone secretion from LβT2 cells by using Gaussia luciferase
por: SATOU, Kazuhiro, et al.
Publicado: (2017)

Revisiting influenza A virus life cycle from a perspective of genome balance
por: Du, Ruikun, et al.
Publicado: (2022)

A high-throughput Gaussia luciferase reporter assay for screening potential gasdermin E activators against pancreatic cancer
por: Liu, Yang, et al.
Publicado: (2023)

Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
por: Du, Ruikun, et al.
Publicado: (2019)

Longitudinal monitoring of Gaussia and Nano luciferase activities to concurrently assess ER calcium homeostasis and ER stress in vivo
por: Wires, Emily S., et al.
Publicado: (2017)

Membrane-bound Gaussia luciferase as a tool to track shedding of membrane proteins from the surface of extracellular vesicles
por: Zaborowski, Mikołaj Piotr, et al.
Publicado: (2019)

A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus
por: Zhao, Xiujuan, et al.
Publicado: (2019)

Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody–Gaussia Luciferase Fusion Protein
por: Hersh, Jessica, et al.
Publicado: (2023)

A Gaussia Luciferase Cell-Based System to Assess the Infection of Cell Culture- and Serum-Derived Hepatitis C Virus
por: Koutsoudakis, George, et al.
Publicado: (2012)

Secreted Gaussia princeps Luciferase as a Reporter of Escherichia coli Replication in a Mouse Tissue Cage Model of Infection
por: Liu, Mingyu, et al.
Publicado: (2014)

Solution structure of Gaussia Luciferase with five disulfide bonds and identification of a putative coelenterazine binding cavity by heteronuclear NMR
por: Wu, Nan, et al.
Publicado: (2020)

Development of a highly sensitive Gaussia luciferase immunoprecipitation assay for the detection of antibodies against African swine fever virus
por: Ding, Jingjing, et al.
Publicado: (2022)

Small Molecule Inhibitors of Influenza Virus Entry
por: Chen, Zhaoyu, et al.
Publicado: (2021)

SARS-CoV-2 cell entry and targeted antiviral development
por: Chen, Zinuo, et al.
Publicado: (2021)

Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors
por: Li, Ping, et al.
Publicado: (2020)

A codon-optimized luciferase from Gaussia princeps facilitates the in vivo monitoring of gene expression in the model alga Chlamydomonas reinhardtii
por: Shao, Ning, et al.
Publicado: (2008)

Listeria innocua Dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX
por: Al-Ani, Ali W., et al.
Publicado: (2019)

Evaluation of Gaussia luciferase and foot-and-mouth disease virus 2A translational interrupter chimeras as polycistronic reporters for transgene expression
por: Puckette, Michael, et al.
Publicado: (2017)

Optimization and applications of an in vivo bioluminescence imaging model of influenza A virus infections
por: Lin, Xiaojing, et al.
Publicado: (2023)

Rapid and sensitive large-scale screening of low affinity extracellular receptor protein interactions by using reaction induced inhibition of Gaussia luciferase
por: Galaway, Francis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t47spsr4nmkhogbchoue964ih2